# Amphastar Pharmaceuticals, Inc. (AMPH) FY2026 Q2 Balance Sheet

- Company: Amphastar Pharmaceuticals, Inc. (AMPH)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-06, accession number 0001297184-26-000047
- Page: https://plicit.ai/financials/amph/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/amph-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 1,743,766,000 US dollars
- **Current assets**: 630,951,000 US dollars
- **Non-current assets**: 1,112,815,000 US dollars
- **Liabilities**: 975,609,000 US dollars
- **Current liabilities**: 263,205,000 US dollars
- **Non-current liabilities**: 712,404,000 US dollars
- **Equity**: 768,157,000 US dollars
- **Cash and cash equivalents**: 223,614,000 US dollars
- **Inventories**: 179,907,000 US dollars
- **Accounts receivable, net**: 144,857,000 US dollars
- **Short-term investments**: 66,509,000 US dollars
- **Prepaid expenses and other assets**: 11,001,000 US dollars
- **Income tax refunds and deposits**: 2,628,000 US dollars
- **Restricted short-term investments**: 2,200,000 US dollars
- **Restricted cash**: 235,000 US dollars
- **Goodwill and intangible assets, net**: 647,833,000 US dollars
- **Property, plant, and equipment**: 316,063,000 US dollars
- **Operating lease right-of-use assets**: 72,911,000 US dollars
- **Deferred tax assets**: 42,464,000 US dollars
- **Other assets**: 33,392,000 US dollars
- **Finance lease right-of-use assets**: 152,000 US dollars
- **Accounts payable and accrued liabilities**: 251,371,000 US dollars
- **Current portion of operating lease liabilities**: 8,800,000 US dollars
- **Current portion of long-term debt**: 2,488,000 US dollars
- **Income taxes payable**: 546,000 US dollars
- **Long-term debt, net of current portion and unamortized debt issuance costs**: 609,564,000 US dollars
- **Long-term operating lease liabilities, net of current portion**: 67,470,000 US dollars
- **Other long-term liabilities**: 29,444,000 US dollars
- **Long-term reserve for income tax liabilities**: 5,926,000 US dollars
- **Retained earnings**: 703,649,000 US dollars
- **Additional paid-in capital**: 553,002,000 US dollars
- **Common stock: par value $0.0001; 300,000,000 shares authorized; 62,306,254 and 42,532,225 shares issued and outstanding, respectively, as of June 30, 2026 and 61,779,883 and 45,645,497 shares issued and outstanding, respectively, as of December 31, 2025**: 6,000 US dollars
- **Treasury stock**: negative 482,596,000 US dollars
- **Accumulated other comprehensive loss**: negative 5,904,000 US dollars
- **Gross equity (calculated)**: 1,256,657,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.